The RPS17 Gene Diamond-Blackfan Anemia Type 4 Genetic Test is a specialized diagnostic assessment performed to identify mutations in the RPS17 gene, which are associated with Diamond-Blackfan Anemia (DBA) Type 4. DBA is a rare, inherited bone marrow failure disorder characterized by anemia that typically presents in infancy or early childhood. The disorder results from defects in ribosome synthesis, and the RPS17 gene, coding for a component of the ribosome, is one of the several genes implicated in this condition.
This genetic test involves analyzing the patient's DNA to detect mutations in the RPS17 gene that are known to cause DBA Type 4. Identifying these mutations can confirm a diagnosis of DBA Type 4, which is crucial for the management and treatment of the condition. It also provides valuable information for family planning and genetic counseling for affected families.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, reflecting the comprehensive analysis and the specialized technology required to accurately identify mutations in the RPS17 gene. The results from this test can help guide clinical decisions, including the need for bone marrow transplantation, and enable affected families to receive tailored support and counseling.
The "RPL35A Gene Diamond-Blackfan Anemia Type 5 Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the RPL35A gene, which are associated with Diamond-Blackfan Anemia (DBA) Type 5. DBA is a rare genetic disorder characterized by the failure of the bone marrow to produce adequate red blood cells, leading to severe anemia and a host of other potential complications. This test is crucial for the early detection and management of the condition, enabling personalized treatment plans and genetic counseling for affected families.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for specific genetic alterations in the RPL35A gene. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed in the detection process. By identifying the genetic underpinnings of DBA Type 5, this test plays a pivotal role in improving the quality of life for patients through targeted therapies and interventions, while also offering valuable information for family planning and the understanding of the disorder's inheritance patterns.
The RPL5 Gene Diamond-Blackfan Anemia Type 6 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the RPL5 gene, which are linked to Diamond-Blackfan Anemia (DBA) Type 6. Diamond-Blackfan Anemia is a rare inherited bone marrow failure syndrome characterized by an inability to produce red blood cells, leading to severe anemia and various other congenital abnormalities. The RPL5 gene plays a crucial role in the production of ribosomes, which are essential for protein synthesis within cells. Mutations in this gene disrupt normal ribosome function, which is a hallmark of DBA.
This genetic test involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific mutations in the RPL5 gene. Identifying these mutations can confirm a diagnosis of DBA Type 6, which is crucial for developing an effective treatment plan and providing genetic counseling. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accurate and reliable results. Early diagnosis through this genetic test can significantly improve the quality of life for affected individuals by enabling timely interventions and management of symptoms associated with Diamond-Blackfan Anemia.
The RPL11 Gene Diamond-Blackfan Anemia Type 7 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RPL11 gene associated with Diamond-Blackfan Anemia (DBA) Type 7. DBA is a rare inherited bone marrow failure disorder characterized by the inability to produce sufficient red blood cells, leading to severe anemia and various congenital anomalies. The test is crucial for the accurate diagnosis of DBA Type 7, enabling healthcare professionals to tailor appropriate treatment and management strategies for affected individuals.
Performed through a blood sample, the test examines the RPL11 gene for specific mutations known to cause this subtype of anemia. Early diagnosis through genetic testing is vital, as it helps in managing symptoms, preventing complications, and improving the quality of life of patients with DBA. The test cost is 4400 AED at DNA Labs UAE, reflecting the specialized nature of the analysis and the sophisticated technology employed to achieve accurate results. This genetic test is a key step towards personalized medicine for patients with Diamond-Blackfan Anemia Type 7, offering hope for better-targeted therapies and interventions.
The HSPA9 gene anemia sideroblastic type 4 genetic test is a specialized diagnostic procedure designed to identify mutations in the HSPA9 gene, which are implicated in causing sideroblastic anemia type 4. This form of anemia is characterized by the body's inability to properly incorporate iron into hemoglobin, leading to inefficient oxygen transport in the blood and a buildup of iron within cells. The test is crucial for individuals exhibiting symptoms of sideroblastic anemia or those with a family history of the condition, as it can provide a definitive diagnosis and guide treatment options.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw, and analyzing the genetic material for specific mutations in the HSPA9 gene. The cost of the test is set at 4400 AED, reflecting the intricate technology and expertise required to accurately identify the genetic variations associated with this rare form of anemia.
Upon completion, the results can offer valuable insights into the genetic underpinnings of the patient's condition, enabling personalized treatment plans that can significantly improve quality of life. Given the complexity of genetic disorders, the HSPA9 gene anemia sideroblastic type 4 genetic test represents a crucial step towards precise and effective management of this challenging condition.
The ABCB7 Gene Anemia sideroblastic with ataxia genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the ABCB7 gene, which are linked to a rare condition known as X-linked sideroblastic anemia and ataxia (XLSA/A). This condition is characterized by a combination of sideroblastic anemia, where the body has difficulty incorporating iron into hemoglobin, and ataxia, a neurological disorder that affects balance, coordination, and speech. The test aims to provide crucial genetic information that can aid in the accurate diagnosis and management of the condition, facilitating personalized treatment plans and genetic counseling for affected individuals and their families. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed reporting provided by DNA Labs UAE.
The ALAS2 Gene Anemia Sideroblastic X-linked Genetic Test is a specialized diagnostic tool designed to identify mutations in the ALAS2 gene, which are responsible for X-linked sideroblastic anemia. This condition is a form of anemia characterized by the body's inability to properly incorporate iron into hemoglobin, leading to inefficient red blood cell production and an accumulation of iron within cells. The ALAS2 gene plays a critical role in heme synthesis, and mutations in this gene disrupt the normal production of hemoglobin, the oxygen-carrying component of red blood cells.
This genetic test involves analyzing the patient's DNA to detect any mutations in the ALAS2 gene. It is a crucial step for accurate diagnosis and management of X-linked sideroblastic anemia, enabling healthcare providers to tailor treatments that address the specific genetic mutation present. Early diagnosis and intervention can significantly improve the quality of life for affected individuals.
The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the ALAS2 Gene Anemia Sideroblastic X-linked Genetic Test is 3200 AED. DNA Labs UAE utilizes state-of-the-art technology and follows stringent protocols to ensure the accuracy and reliability of test results, providing patients and healthcare providers with crucial information for the effective management of X-linked sideroblastic anemia.
The "GATA1 Gene Anemia X-linked Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the GATA1 gene, which are associated with various forms of anemia and blood disorders inherited in an X-linked manner. This gene plays a crucial role in the regulation of hematopoiesis, the process by which the body produces blood cells. Mutations in GATA1 can lead to conditions such as X-linked anemia, thrombocytopenia, and certain types of leukemia, making early and accurate diagnosis vital for effective management and treatment.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the GATA1 gene to detect any genetic abnormalities that may be affecting blood cell production and function. The test is particularly relevant for individuals with a family history of blood disorders or those exhibiting symptoms related to anemia and other hematological conditions.
The cost of the GATA1 Gene Anemia X-linked Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the intricate technology and expertise required to accurately identify mutations in the GATA1 gene and provide patients and healthcare providers with critical information for the management of associated conditions.
The HP Gene Anhaptoglobinemia Genetic Test, available at DNA Labs UAE for a cost of 4400 AED, is a specialized diagnostic procedure aimed at identifying anhaptoglobinemia, a rare genetic condition characterized by the absence of haptoglobin in the blood. Haptoglobin is a protein responsible for binding free hemoglobin released from red blood cells, thus preventing it from causing harm to the body. Anhaptoglobinemia can lead to various health issues, including an increased risk of hemolytic anemia and cardiovascular disease.
This test specifically looks for mutations in the HP gene, which is responsible for the production of haptoglobin. By analyzing a sample of the patient's DNA, the test can confirm the presence of these genetic alterations, providing crucial information for diagnosis and potential management of the condition. Conducted at the state-of-the-art facilities of DNA Labs UAE, the test adheres to high standards of accuracy and reliability, offering individuals a comprehensive understanding of their genetic health in relation to anhaptoglobinemia.
The "RFX5 Gene Bare Lymphocyte Syndrome Type 2 Complementation Group C Genetic Test" is a specialized diagnostic examination conducted at DNA Labs UAE. This test is designed to identify mutations in the RFX5 gene, which are associated with Bare Lymphocyte Syndrome Type 2, Complementation Group C. Bare Lymphocyte Syndrome Type 2 is a rare immunodeficiency disorder characterized by a reduced expression of Major Histocompatibility Complex (MHC) class II molecules, leading to a severe impairment in the immune system's ability to fight infections. The RFX5 gene plays a crucial role in the regulation of MHC class II genes, and mutations in this gene can disrupt this process, leading to the condition.
The test involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific genetic alterations in the RFX5 gene that are known to cause the syndrome. It is a critical tool for the diagnosis and management of individuals suspected to have this condition, enabling healthcare providers to tailor treatment strategies according to the genetic makeup of the patient.
The cost of the test is set at 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results accurately. Conducted at DNA Labs UAE, a facility renowned for its advanced genetic testing capabilities and commitment to providing high-quality healthcare services, this test represents a crucial step forward in the personalized treatment of immune disorders.
